About Immunai

Immunai is an AI-powered biotechnology platform that maps and analyzes the human immune system to improve drug discovery and clinical trials. It uses advanced machine learning and single-cell biology to understand how immune cells behave in different diseases and how patients respond to treatments. The goal is to make drug development faster, more accurate, and more personalized, especially in areas like cancer and autoimmune diseases.

Platforms:

Feature Highlights

Use Cases

Common
Uncommon
Description
Improving clinical trials by selecting better patient groups
Helping pharmaceutical companies develop new drugs faster
Studying cancer and autoimmune disease immune responses
Finding biomarkers that predict treatment success
Reducing drug development cost and failure risk
Supporting precision medicine research